Inventor · disambiguated record
Paul Tempest
Also filed as: TEMPEST PAUL · TEMPEST PAUL J
29 granted patents·7 pending applications·158 citations·filing 2006–2024
96Inventor score
Files withMERCK SHARP & DOHME16APRINOIA THERAPEUTICS LTD6TOCOPHERX INC3APRINOIA THERAPEUTICS INC2HARRINGTON PAUL2
Top patents by PatentIndex Score
36 records- 0193US7981874B2Phosphorus derivatives as histone deacetylase inhibitorsMERCK SHARP & DOHME·Filed 2007·Granted Jul 19, 2011·21 cites·17 claims
- 0293US7544695B2Spirocyclic compoundsMERCK & CO INC·Filed 2006·Granted Jun 9, 2009·29 cites·14 claims
- 0391US8686020B2Spirocyclic compoundsMERCK SHARP & DOHME·Filed 2012·Granted Apr 1, 2014·17 cites·6 claims
- 0491US8349825B2Spirocyclic compoundsMERCK SHARP & DOHME·Filed 2010·Granted Jan 8, 2013·18 cites·6 claims
- 0590US8026260B2Histone deacetylase inhibitors with aryl-pyrazolyl-motifsMERCK SHARP & DOHME·Filed 2006·Granted Sep 27, 2011·9 cites·15 claims
- 0690US7834026B2Spirocyclic compoundsMERCK SHARP & DOHME·Filed 2006·Granted Nov 16, 2010·17 cites·6 claims
- 0784US11291732B1Compounds for degrading α-synuclein aggregates and uses thereofAPRINOIA THERAPEUTICS LTD·Filed 2021·Granted Apr 5, 2022·1 cites·18 claims
- 0884US2025101018A1Heteroaryl compounds and uses thereofAPRINOIA THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0981US12116364B2Heteroaryl compounds and uses thereofAPRINOIA THERAPEUTICS INC·Filed 2019·Granted Oct 15, 2024·2 cites·14 claims
- 1081US10011615B2Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist propertiesMERCK SHARP & DOHME·Filed 2017·Granted Jul 3, 2018·3 cites·14 claims
- 1181US8389553B24-carboxybenzylamino derivatives as histone deacetylase inhibitorsHARRINGTON PAUL·Filed 2008·Granted Mar 5, 2013·5 cites·2 claims
- 1279US9096559B24-carboxybenzylamino derivatives as histone deacetylase inhibitorsHARRINGTON PAUL·Filed 2013·Granted Aug 4, 2015·5 cites·3 claims
- 1379US8367706B2Inhibitors of janus kinasesMERCK SHARP & DOHME·Filed 2008·Granted Feb 5, 2013·5 cites·8 claims
- 1479US8158825B2Modified malonate derivativesGRIMM JONATHAN·Filed 2006·Granted Apr 17, 2012·9 cites·17 claims
- 1578US2023374006A1Heteroaryl compounds and uses thereofAPRINOIA THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1677US7763634B2Inhibitors of janus kinasesMERCK & CO INC·Filed 2007·Granted Jul 27, 2010·3 cites·7 claims
- 1776US9493440B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Nov 15, 2016·2 cites·18 claims
- 1876US2023346955A1Compounds for degrading tau protein aggregates and uses thereofAPRINOIA THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1975US10822338B2Substituted aminoquinazoline compounds as A2A antagonistMERCK SHARP & DOHME·Filed 2016·Granted Nov 3, 2020·2 cites·17 claims
- 2073US12377152B2Compounds for degrading alpha-synuclein aggregates and uses thereofAPRINOIA THERAPEUTICS LTD·Filed 2022·Granted Aug 5, 2025·0 cites·18 claims
- 2173US9676780B2Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2013·Granted Jun 13, 2017·2 cites·15 claims
- 2272US9416126B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Aug 16, 2016·2 cites·18 claims
- 2371US11642413B2Compounds for degrading Tau protein aggregates and uses thereofAPRINOIA THERAPEUTICS LTD·Filed 2022·Granted May 9, 2023·0 cites·30 claims
- 2471US10208055B2Pyrazole compounds as modulators of FSHR and uses thereofTOCOPHERX INC·Filed 2014·Granted Feb 19, 2019·2 cites·13 claims
- 2571US9688654B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Jun 27, 2017·1 cites·10 claims
- 2671US8119652B2Aryl-fused spirocyclic compoundsHAMBLETT CHRISTOPHER·Filed 2007·Granted Feb 21, 2012·3 cites·6 claims
- 2767US2023047178A1Heteroaryl compounds and uses thereofAPRINOIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2864US10941152B2Pyrazole compounds as modulators of FSHR and uses thereofTOCOPHERX INC·Filed 2018·Granted Mar 9, 2021·0 cites·15 claims
- 2960US2022402929A1Pyrazole compounds as modulators of fshr and uses thereofTOCOPHERX INC·Filed 2021·Application pending·0 cites
- 3045US2010216796A1N-hydroxy-naphthalene dicarboxamide and n-hydroxy-biphenyl-dicarboxamide compounds as histone deacetylase inhibitorsKATTAR SOLOMON·Filed 2008·Application pending·0 cites
- 3143US11046714B22,2-difluorodioxolo A2A receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Jun 29, 2021·0 cites·14 claims
- 3242US11655216B2Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted May 23, 2023·0 cites·8 claims
- 3340US10961215B2N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted Mar 30, 2021·0 cites·19 claims
- 3440US8759579B2Cyclobutyl sulfones as notch sparing gamma secretase inhibitorsHEIDEBRECHT RICHARD W·Filed 2009·Granted Jun 24, 2014·0 cites·14 claims
- 3539US10894775B2Piperidine derivatives as liver X receptor beta agonists, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted Jan 19, 2021·0 cites·12 claims
- 3637US2013102605A1Inhibitors of akt activityLIANG PENG·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Tempest files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →